180 related articles for article (PubMed ID: 37876941)
1. Risk of head and neck cancer in relation to blood inflammatory biomarkers in the Swedish AMORIS cohort.
Yang Y; Liang Y; Sadeghi F; Feychting M; Hamar N; Fang F; Zhang Z; Liu Q
Front Immunol; 2023; 14():1265406. PubMed ID: 37876941
[TBL] [Abstract][Full Text] [Related]
2. Blood metabolic biomarkers and the risk of head and neck cancer: An epidemiological study in the Swedish AMORIS Cohort.
Huang Y; Xiao X; Sadeghi F; Feychting M; Hammar N; Fang F; Zhang Z; Liu Q
Cancer Lett; 2023 Mar; 557():216091. PubMed ID: 36764441
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.
Sollie S; Michaud DS; Sarker D; Karagiannis SN; Josephs DH; Hammar N; Santaolalla A; Walldius G; Garmo H; Holmberg L; Jungner I; Van Hemelrijck M
BMC Cancer; 2019 Aug; 19(1):858. PubMed ID: 31464604
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Profile and Long-Term Risk of Depression, Anxiety, and Stress-Related Disorders.
Chourpiliadis C; Zeng Y; Lovik A; Wei D; Valdimarsdóttir U; Song H; Hammar N; Fang F
JAMA Netw Open; 2024 Apr; 7(4):e244525. PubMed ID: 38564219
[TBL] [Abstract][Full Text] [Related]
5. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
[TBL] [Abstract][Full Text] [Related]
6. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis.
Tham T; Olson C; Khaymovich J; Herman SW; Costantino PD
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1663-1670. PubMed ID: 29651542
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort.
Xiao X; Huang Y; Sadeghi F; Feychting M; Hammar N; Fang F; Zhang Z; Liu Q
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672472
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
10. Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum.
Ghoshal A; Garmo H; Arthur R; Carroll P; Holmberg L; Hammar N; Jungner I; Malmström H; Lambe M; Walldius G; Van Hemelrijck M
Oncotarget; 2018 Jan; 9(1):774-782. PubMed ID: 29416653
[TBL] [Abstract][Full Text] [Related]
11. Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study.
Kawakita D; Abdelaziz S; Chen Y; Rowe K; Snyder J; Fraser A; Smith K; Herget K; Deshmukh V; Newman M; Monroe M; Hashibe M
Cancer; 2020 Feb; 126(4):879-885. PubMed ID: 31721181
[TBL] [Abstract][Full Text] [Related]
12. The value of lymphocyte to monocyte ratio in the prognosis of head and neck squamous cell carcinoma: a meta-analysis.
Wei D; Liu J; Ma J
PeerJ; 2023; 11():e16014. PubMed ID: 37719125
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of dynamic changes in lymphocyte-to-monocyte ratio in patients with head and neck cancer treated with radiotherapy: results from a large cohort study.
Lin CH; Chou WC; Wu YY; Lin CY; Chang KP; Liao CT; Ho TY; Yeh CM; Liu CJ; Hung SP; Lee CH; Chen PJ; Chou YC; Fan KH; Huang BS; Tung-Chieh Chang J; Wang CC; Tsang NM
Radiother Oncol; 2021 Jan; 154():76-86. PubMed ID: 32941957
[TBL] [Abstract][Full Text] [Related]
14. Use of nonaspirin nonsteroidal anti-inflammatory drugs and risk of head and neck cancer: A nationwide case-control study.
de la Cour CD; Dehlendorff C; Aalborg GL; von Buchwald C; Friis S; Verdoodt F; Kjaer SK
Int J Cancer; 2020 Apr; 146(8):2139-2146. PubMed ID: 31265123
[TBL] [Abstract][Full Text] [Related]
15. Association of Immigration Status and Chinese and South Asian Ethnicity With Incidence of Head and Neck Cancer.
Noel CW; Sutradhar R; Li Q; Forner D; Hallet J; Cheung M; Singh S; Coburn NG; Eskander A
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1125-1135. PubMed ID: 33151263
[TBL] [Abstract][Full Text] [Related]
16. Association of Metabolic Syndrome with the Risk of Head and Neck Cancer: A 10-Year Follow-Up Study of 10 Million Initially Healthy Individuals.
Kim GJ; Han KD; Joo YH
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627146
[TBL] [Abstract][Full Text] [Related]
17. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study.
Arthur R; Williams R; Garmo H; Holmberg L; Stattin P; Malmström H; Lambe M; Hammar N; Walldius G; Robinsson D; Jungner I; Van Hemelrijck M
Int J Cancer; 2018 Jun; 142(11):2254-2262. PubMed ID: 29322512
[TBL] [Abstract][Full Text] [Related]
18. Toenail selenium status and risk of subtypes of head-neck cancer: The Netherlands Cohort Study.
Maasland DH; Schouten LJ; Kremer B; van den Brandt PA
Eur J Cancer; 2016 Jun; 60():83-92. PubMed ID: 27082137
[TBL] [Abstract][Full Text] [Related]
19. Blood-Based Biomarkers and Long-term Risk of Frailty-Experience From the Swedish AMORIS Cohort.
Wennberg AM; Ding M; Ebeling M; Hammar N; Modig K
J Gerontol A Biol Sci Med Sci; 2021 Aug; 76(9):1643-1652. PubMed ID: 33979435
[TBL] [Abstract][Full Text] [Related]
20. Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study.
Santaolalla A; Sollie S; Rislan A; Josephs DH; Hammar N; Walldius G; Garmo H; Karagiannis SN; Van Hemelrijck M
BMC Immunol; 2021 Sep; 22(1):61. PubMed ID: 34488637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
